NYSEAMERICAN:HEB - Hemispherx BioPharma Price Target & Analyst Ratings

$4.07
+0.01 (+0.25 %)
(As of 07/18/2019 03:32 AM ET)
Today's Range
$3.86
Now: $4.07
$4.40
50-Day Range N/A
52-Week Range
$3.62
Now: $4.07
$14.81
Volume342,200 shs
Average Volume101,512 shs
Market Capitalization$8.00 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

Hemispherx BioPharma (NYSEAMERICAN:HEB) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Hemispherx BioPharma in the last 12 months. Their average twelve-month price target is $26.00, suggesting that the stock has a possible upside of 538.82%. The high price target for HEB is $44.00 and the low price target for HEB is $8.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyN/AN/A
Consensus Rating Score: 3.003.00N/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $26.00$26.00N/AN/A
Price Target Upside: 538.82% upside385.98% upsideN/AN/A

Hemispherx BioPharma (NYSEAMERICAN:HEB) Consensus Price Target History

Hemispherx BioPharma (NYSEAMERICAN:HEB) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
6/14/2019Maxim GroupInitiated CoverageBuy$8.00View Rating Details
5/17/2019Ascendiant Capital MarketsSet Price TargetBuy$44.00View Rating Details
(Data available from 7/18/2017 forward)
This page was last updated on 7/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel